|
Home
About Us
Founding Director
Mission Statement
Team
Faculty
Research Staff
Administration
Students
Contact Us
Career Opportunities
Sponsors
Programs
FEEAP
Overview
Current Field Evaluations
Completed Field Evaluations
HTAP
Overview
Current HTAP Projects
Completed HTAP Projects
TEMMP
Overview
Current TEMMP Projects
Completed TEMMP Projects
SHARP
Overview
HELP
Overview
HELP Educational Activities
Expertise
Comparative Effectiveness Research
Trial Design, Management and Analysis
Evidence-Based Reviews and Synthesis
Patient Reported Outcomes
Decision Analytic Modelling
Pricing, Reimbursement and Market Access
Knowledge Translation & Healthcare Policy
Workshops
Modeling Approaches for HTA: A Pracitcal Hands-On Workshop (Austria)
Workshop Objectives
Presenters
Participant Info
Fees/Cancellations
Registration
Workshop Contact
Health Technology Assessment (HTA): From Theory to Evidence to Policy Workshop
Workshop Objectives
Presenters Include:
Participant Info
Fees/Cancellations
Registration
Workshop Contact
Graduate Education
Overview
HRM Courses
Publications & Presentations
Publications
All
Books/Book Chapters
Reports
Peer-Reviewed Journal Articles
Peer-Reviewed Journal Abstracts
PATH Annual Reports
Presentations
All
Invited Conferences
Contributed Conferences
Peer-Reviewed Journal Articles
Bischof M, Leuppi JD, Sendi P. Cost-effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in hip surgery patients.
Expert Review of Pharmacoeconomics and Outcomes Research
2006;6(2):171-80.
Casey R, Tarride JE, Keresteci MA, Torrance GW. The Erectile Function Visual Analog Scale (EF-VAS): a disease-specific utility instrument for the assessment of erectile function.
Canadian Journal of Urology
2006;13(2):3016-25.
Farahani P, Levine M, Gaebel K, Wang ECY, Khalidi N. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
Journal of Rheumatology
2006;33(4):665-70.
Farahani P, Levine M, Goeree R. A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics.
Journal of Evaluation in Clinical Practice
2006;12(4):463-70.
Goeree R, Blackhouse G, Adachi J. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.
Current Medical Research and Opinion
2006;22(7):1425-36.
Goeree R, Levin L. Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process.
PharmacoEconomics
2006;24(11):1143-56.
Gordon A, Choiniere M, Collet JP, Rousseau C, Tarride JE. The humanistic burden of neuropathic pain in Canada.
Journal of Outcomes Research
2006;10(23-35):23-36.
Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, Wong T, Cook R, Solymoss S, Poon MC, Raskob G. Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer.
American Journal of Medicine
2006;119(12):1062-72.
Lachaine J, Rinfret S, Merikle EP, Tarride JE. Persistence and adherence to cholesterol lowering agents: evidence from Regie de l'Assurance Maladie du Quebec data.
American Heart Journal
2006;152(1):164-9.
Loeb M, Carusone SC, Goeree R, Walter SD, Brazil K, Krueger P, Simor A, Moss L, Marrie T. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial.
JAMA
2006;295(21):2503-10.
1
2
3
Next page
For More Information
All
Books/Book Chapters
Reports
Peer-Reviewed Journal Articles
Peer-Reviewed Journal Abstracts
PATH Annual Reports
Search by year
2013
2012
2011
2010
2009
2008
2007
2006
2005
2002
1998
Footer